Original Research

Published on 31 Aug 2023

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma

in Drugs Outcomes Research and Policies

Yufan Huang
Maojin You
Qundan Wu
Ruijia Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1238009

3,037 views
1 citation

Review

Published on 31 Aug 2023

The challenges of access to innovative medicines with limited evidence in the European Union

in Drugs Outcomes Research and Policies

Antonio Vallano
Caridad Pontes
Antònia Agustí

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1215431

3,559 views

Original Research

Published on 31 Aug 2023

Community pharmacists’ skills and practice regarding dispensing fiscalized substances: a cross-sectional survey

in Drugs Outcomes Research and Policies

Faris El-Dahiyat
Ammar Abdulrahman Jairoun
Sabaa Saleh Al-Hemyari
Moyad Shahwan
Maimona Jairoun
Sa’ed H. Zyoud
Ammar Ali Saleh Jaber
Mustfa Faisal Alkhanani
Reem Hasaballah Alhasani
Ahmed M. Ashour

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237306

2,108 views

Review

Published on 31 Aug 2023

Reasons that lead people to buy prescription medicines on the internet: a systematic review

in Drugs Outcomes Research and Policies

Hamzeh Almomani
Amna Raza
Nilesh Patel
Parastou Donyai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239507

8,711 views
5 citations

Original Research

Published on 30 Aug 2023

Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement

in Drugs Outcomes Research and Policies

Wen Zhang
Qingwen Xu
Jing Peng
Xiaotong Zhang
Lu Chen
Yilai Wu
Kui Yang
Jiajie Luan
Xiaoyun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233491

2,404 views
5 citations

Review

Published on 29 Aug 2023

Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

in Drugs Outcomes Research and Policies

Ratul Bhowmik
Ravi Kant
Ajay Manaithiya
Daman Saluja
Bharti Vyas
Ranajit Nath
Kamal A. Qureshi
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265573

3,800 views
5 citations

Opinion

Published on 29 Aug 2023

Extended anticoagulation for VTE: what evidence justifies it?

in Drugs Outcomes Research and Policies

Anushka Walia
Vinay Prasad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241979

2,444 views

Perspective

Published on 28 Aug 2023

Combatting the rising costs of cancer drugs; interventions from a university hospital’s perspective

in Drugs Outcomes Research and Policies

Aniek Dane
Roelof van Leeuwen
Maaike Hoedemakers
Hugo van der Kuy
Stefan Sleijfer

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264951

2,732 views

Perspective

Published on 24 Aug 2023

What could health technology assessment learn from living clinical practice guidelines?

in Drugs Outcomes Research and Policies

Saskia Cheyne
Samantha Chakraborty
Samara Lewis
Sue Campbell
Tari Turner
Sarah Norris

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1234414

2,144 views
2 citations

Original Research

Published on 24 Aug 2023

Aripiprazole-induced liver injury: a spontaneous reporting database study

in Drugs Outcomes Research and Policies

Yunjuan Gao
Chengzhao Wu
Xingran Zhai
Ming Niu
Zhaofang Bai
Haibo Song
Xu Zhao
Jiabo Wang
Xiaohe Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226386

4,792 views
3 citations

Systematic Review

Published on 24 Aug 2023

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Mengnan Zhao
Zhaoyan Chen
Ting Xu
Ping Fan
Fangyuan Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1221069

6,434 views
8 citations

Systematic Review

Published on 24 Aug 2023

Local injection therapy for carpal tunnel syndrome: a network meta-analysis of randomized controlled trial

in Drugs Outcomes Research and Policies

TianQi Zhou
ZhuoRao Wu
XingYun Gou
HaiSha Xia
JiLin Ding
ShuangChun Ai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140410

3,649 views
4 citations

Original Research

Published on 24 Aug 2023

An international comparative analysis and roadmap to sustainable biosimilar markets

in Drugs Outcomes Research and Policies

Khalid A. Alnaqbi
Agnès Bellanger
Alex Brill
Gilberto Castañeda-Hernández
Ana Clopés Estela
Olga Delgado Sánchez
Pilar García-Alfonso
Pius Gyger
Daniel Heinrich
Germain Hezard

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188368

8,229 views
11 citations

Original Research

Published on 23 Aug 2023

Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study

in Drugs Outcomes Research and Policies

Lingyan Gao
Yalei Han
Zhankun Jia
Pengfei Wang
Meijing Zhang
Teng Ma
Suying Yan
Hua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249636

2,697 views
2 citations

Original Research

Published on 23 Aug 2023

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma

in Drugs Outcomes Research and Policies

Min Hu
Yiduo Ding
Haizhou Zhang
Wei Guo
Yun Li
Zhengming Jin
Changju Qu
Fan Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195907

1,329 views

Brief Research Report

Published on 22 Aug 2023

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model

in Drugs Outcomes Research and Policies

Aparna Narendrula
Jacob Lang
Elias Mossialos

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1179253

4,175 views
2 citations

Navigation group

Articles

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma

The challenges of access to innovative medicines with limited evidence in the European Union

Community pharmacists’ skills and practice regarding dispensing fiscalized substances: a cross-sectional survey

Reasons that lead people to buy prescription medicines on the internet: a systematic review

Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement

Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

Extended anticoagulation for VTE: what evidence justifies it?

Combatting the rising costs of cancer drugs; interventions from a university hospital’s perspective

What could health technology assessment learn from living clinical practice guidelines?

Aripiprazole-induced liver injury: a spontaneous reporting database study

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis

Local injection therapy for carpal tunnel syndrome: a network meta-analysis of randomized controlled trial

An international comparative analysis and roadmap to sustainable biosimilar markets

Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model